This article has been withdrawn by the authors. The corresponding author identified some issues and brought them to the attention of the Journal. The following issues were discovered in the article. Lanes 1-3 were duplicated in lanes 5-6 of the c-caspase 3 immunoblot in Fig. 2C . The Nrf2 immunoblot from BEAS-2B cells from Fig. 5D was reused in Fig. 8A . In Fig. 8C , the first two lanes of the p62 ARE F1 and the ␤-actin gels were duplicated. Additionally, lanes 1 and 8 of the p62 ARE F4 gel were duplicated. In Fig. 9C, lanes 2 and 5 of the Bcl-xL ARE R1 gel were duplicated. In Fig. 9F, lanes 1 and 2 were reused in lanes 5 and 6 of the Bcl-2 ARE F1 gel. In Fig. 11B, lanes 3 and 5 of the Nrf2 immunoblot were duplicated. Additionally, lanes 4 and 6 of the lower bands in the LC3 immunoblot were duplicated. In Fig. 11C , the SOD1 immunoblot was reused as the SOD2.
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